F-star Therapeutics, Inc.
FSTXDelisted Mar 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566373
F-star Therapeutics, Inc. was delisted on Mar 9, 2023; its insiders filed their last Form 4 on Mar 9, 2023; 59 institutions reported holding it in 13F filings for Q4 2022, worth $57.8M in total; Fairfax Financial was the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding F-star Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 54 | 1 | 59 | +6 |
| Shares | 6.92M | 40.0K | 9.14M | +2.26M (+32.8%) |
| Value | $35.5M | $205.0K | $57.8M | +$22.5M (+63.9%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held F-star Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 1,000,000 | $6.32M | 0.17% |
| Trium Capital LLP | 679,744 | $4.30M | 1.97% |
| Weiss Asset Management LP | 548,189 | $3.46M | 0.17% |
| Crystalline Management Inc. | 375,000 | $2.37M | 1.19% |
| Quinn Opportunity Partners LLC | 179,705 | $1.14M | 0.14% |
| Vazirani Asset Management LLC | 125,000 | $790.0K | 1.35% |
| TLS Advisors LLC | 54,298 | $343.0K | 1.69% |
| Ridgeback Capital Investments L.P. | 52,509 | $331.9K | 0.40% |
| Brookfield Asset Management Inc. | 50,000 | $316.0K | 0.00% |
| Man Group plc | 42,411 | $268.0K | 0.00% |
| Shay Capital LLC | 23,456 | $148.2K | 0.09% |
| Virtu Financial LLC | 13,933 | $88.0K | 0.01% |
| Charles Schwab Investment Management Inc | 13,596 | $85.9K | 0.00% |
| Group One Trading, L.P. | 175 | $1.11K | 0.00% |
| JPMorgan Chase & Co | 78 | $0 | 0.00% |
Sold out (9)
Institutions that held F-star Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Knott David M Jr | 235,945 | $1.21M |
| AlphaCentric Advisors LLC | 165,000 | $845.0K |
| Ergoteles LLC | 148,354 | $760.0K |
| HRT Financial LP | 109,120 | $558.0K |
| Citadel Advisors LLC | 49,708 | $255.0K |
| Maven Securities LTD | 48,901 | $250.0K |
| Diametric Capital, LP | 44,449 | $228.0K |
| Balyasny Asset Management LLC | 14,483 | $74.0K |
| Simplex Trading, LLC | 340 | $1.00K |
Not filed for Q4 2022 yet (1)
Institutions that held F-star Therapeutics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| S. Muoio & Co. LLC | 40,000 | $205.0K |